Your browser doesn't support javascript.
loading
Will Aquablation Be the New Benchmark for Robotic Minimally Invasive Surgical Treatment for Benign Prostatic Hyperplasia?
Nedbal, Carlotta; Castellani, Daniele; De Stefano, Virgilio; Giulioni, Carlo; Nicoletti, Rossella; Pirola, Giacomo; Teoh, Jeremy Yuen-Chun; Elterman, Dean; Somani, Bhaskar Kumar; Gauhar, Vineet.
Afiliação
  • Nedbal C; Urology Unit, Azienda Ospedaliero-Universitaria delle Marche, Università Politecnica delle Marche, Ancona, Italy; Department of Urology, University Hospital Southampton NHS Trust, Southampton, UK. Electronic address: carlottanedbal@gmail.com.
  • Castellani D; Urology Unit, Azienda Ospedaliero-Universitaria delle Marche, Università Politecnica delle Marche, Ancona, Italy.
  • De Stefano V; Urology Unit, Azienda Ospedaliero-Universitaria delle Marche, Università Politecnica delle Marche, Ancona, Italy.
  • Giulioni C; Urology Unit, Azienda Ospedaliero-Universitaria delle Marche, Università Politecnica delle Marche, Ancona, Italy.
  • Nicoletti R; Department of Surgery, S.H. Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong, China; Unit of Urological Robotic Surgery and Renal Transplantation, Careggi Hospital, University of Florence, Florence, Italy.
  • Pirola G; Urology Unit, San Giuseppe Hospital, Multimedica Group, Milan, Italy.
  • Teoh JY; Department of Surgery, S.H. Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong, China.
  • Elterman D; Division of Urology, Department of Surgery, University Health Network, University of Toronto, Toronto, Canada.
  • Somani BK; Department of Urology, University Hospital Southampton NHS Trust, Southampton, UK.
  • Gauhar V; Department of Urology, Ng Teng Fong General Hospital, Singapore.
Eur Urol Focus ; 2023 Dec 29.
Article em En | MEDLINE | ID: mdl-38160171
ABSTRACT
BACKGROUND AND

OBJECTIVE:

Aquablation is included in the European Association Urology guidelines as an alternative surgical technique for prostate resection. The evidence summary states that it is subjectively and objectively as effective as transurethral resection of the prostate (TURP) and enucleation, but concerns remain regarding postoperative bleeding. Our aim was to provide an evidence-based overview of the trials, triumphs, and technical challenges of Aquablation.

METHODS:

A literature search in the PubMed, EMBASE, and Scopus databases was performed to identify clinical prospective and retrospective studies and reviews on Aquablation. A total of 54 reports were included. A narrative review of current evidence and an overview of the surgical technique are provided. KEY FINDINGS AND

LIMITATIONS:

Aquablation demonstrates excellent short- and long-term functional outcomes, with a good safety profile comparable to that of TURP. The procedure is efficient and safe, even for very large prostates, with sustained improvements in functional outcomes well maintained up to 5 yr. The unique ability to conduct robotically controlled precise ablation of enlarged tissue while maintaining the sphincter makes Aquablation a very good ejaculation-sparing BPH treatment option. Initial issues with hemostasis have been successfully overcome with the use of gentle bladder-neck cautery after the procedure, allowing for early catheter removal. The above features make Aquablation an attractive minimally invasive technique and show that it is noninferior to holmium laser enucleation. CONCLUSIONS AND CLINICAL IMPLICATIONS Aquablation is a valid alternative to standard resection techniques, showing excellent long-term functional outcomes, good preservation of sexual function, a good safety profile, and good compliance for all prostate sizes and patient ages. Aquablation is still performed in high-volume centers, but the results can easily be emulated in other centers worldwide. ADVANCING PRACTICE Our review indicates that if Aquablation outcomes are emulated globally, this technique could easily become a new benchmark in robotic treatment for BPH. PATIENT

SUMMARY:

Aquablation is a safe and effective surgical technique for treatment for benign enlargement of the prostate, with excellent medium-term outcomes. Although long-term studies are needed, the results are promising and challenge the current surgical and laser techniques used to reduce the size of the prostate gland.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article